Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Novartis, Aduro Biotech partner to accelerate cancer immunotherapy efforts By PBR Staff Writer
Swiss pharmaceutical firm Novartis has entered into a major multiyear collaboration with US-based Aduro Biotech in order to accelerate its cancer immunotherapy efforts.
Automation > IT & Software > News
RXi, MirImmune to develop cancer immunotherapies using sd-rxRNA technology By PBR Staff Writer
US-based RXi Pharmaceuticals and MirImmune have entered into an exclusive license agreement to use RXi's new sd-rxRNA technology in developing new cell-based cancer immunotherapies.
Automation > IT & Software > News GenVec, TheraBiologics to develop new cancer therapeutics By PBR Staff Writer
US-based biopharmaceutical firm GenVec has entered into a collaboration agreement with TheraBiologics to develop neural stem cell mediated cancer therapies.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
Takeda, Immunogen sign potential $440m drug development deal
By PBR Staff Writer
Japan-based Takeda Pharmaceutical Company and US-based ImmunoGen have signed a drug development agreement that could be worth more than $440m.
Automation > IT & Software > News
GSK, Cold Spring Harbor Lab to develop new drugs for obesity and diabetes
By PBR Staff Writer
US-based Cold Spring Harbor Laboratory has entered into partnership with British pharmaceutical firm GlaxoSmithKline (GSK) to develop new treatments for obesity and type 2 diabetes.
Automation > IT & Software > News
ProMetic completes Phase Ib trial of PBI-4050 in CKD patients
By PBR Staff Writer
Canadian biopharmaceutical firm ProMetic Life Sciences has completed a Phase Ib multi-dose clinical trial of its orally active lead drug candidate, PBI-4050, in patients with chronic kidney disease (CKD).
Automation > IT & Software > News
Cannigistics to offer clinical trials software platform for Canadian medical firm
By PBR Staff Writer
Calyx Bio-Ventures' subsidiary Cannigistics Agri-Solutions (Cannigistics) has entered into a memorandum of understanding (MOU) with an unnamed third party group of Canadian medical specialists with respect to the implementation of a clinical trials software platform.
Automation > IT & Software > News
Tokai, Qiagen to develop AR-V7 companion diagnostic for use with galeterone
By PBR Staff Writer
Tokai Pharmaceuticals and Qiagen have expanded their agreement to develop and commercialise an AR-V7 companion diagnostic for use with galeterone, a multi-targeted, oral small molecule drug candidate.
Automation > IT & Software > News
FDA accepts to review Iroko NDA for SoluMatrix Meloxicam in osteoarthritis pain
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted for review Iroko Pharmaceuticals' new drug application (NDA) for SoluMatrix meloxicam, a low dose nonsteroidal anti-inflammatory drug (NSAID), for the proposed indication of management of osteoarthritis pain.
Automation > IT & Software > News
MultiCell, Oxis Biotech to develop three new antibody-drug conjugates
By PBR Staff Writer
MultiCell Immunotherapeutics (MCIT) has signed a research & development (R&D) and product license agreement with Oxis Biotech (OXIS) to develop three new antibody-drug conjugates (ADCs) containing OXIS' lead drug candidates using MCIT's ADC platform technology.
Automation > IT & Software > News
Recro Pharma agrees to buy assets from Alkermes for $170m
By PBR Staff Writer
US-based clinical stage specialty firm Recro Pharma has entered into a definitive agreement to acquire assets from Alkermes for about $170m.
Automation > IT & Software > News
Glide extends subcontract with Pfenex for solid dose formulation of rPA-based anthrax vaccine
By PBR Staff Writer
Glide Technologies has extended a subcontract with Pfenex for solid dose formulation of its recombinant protective antigen (rPA)-based anthrax vaccine, Px563L-mrPA.
Automation > IT & Software > News
Royal Philips, University of California team up on breast cancer screening technology
By PBR Staff Writer
Royal Philips has joined forces with the University of California, Irvine, in a bid to develop standards for breast cancer screening.
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests